{"id":"https://openalex.org/W3088922385","doi":"https://doi.org/10.1016/j.annonc.2020.08.1438","title":"1895MO Three-year follow-up results of the MERIT trial: A Japanese phase II study of nivolumab in malignant pleural mesothelioma","display_name":"1895MO Three-year follow-up results of the MERIT trial: A Japanese phase II study of nivolumab in malignant pleural mesothelioma","publication_year":2020,"publication_date":"2020-09-01","ids":{"openalex":"https://openalex.org/W3088922385","doi":"https://doi.org/10.1016/j.annonc.2020.08.1438","mag":"3088922385"},"language":"en","primary_location":{"id":"doi:10.1016/j.annonc.2020.08.1438","doi":"https://doi.org/10.1016/j.annonc.2020.08.1438","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2020.08.1438","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1016/j.annonc.2020.08.1438","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038101792","display_name":"Hidetoshi Hayashi","orcid":"https://orcid.org/0000-0001-8787-5587","observed_orcids":["https://orcid.org/0000-0001-8787-5587"]},"institutions":[{"id":"https://openalex.org/I916559398","display_name":"Kindai University","ror":"https://ror.org/05kt9ap64","country_code":"JP","type":"education","lineage":["https://openalex.org/I916559398"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"H. Hayashi","raw_affiliation_strings":["Medical Oncology, Kindai University Faculty of Medicine, Osakasayama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Kindai University Faculty of Medicine, Osakasayama, Japan","institution_ids":["https://openalex.org/I916559398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108600604","display_name":"M. Okada","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I113306721","display_name":"Hiroshima University","ror":"https://ror.org/03t78wx29","country_code":"JP","type":"education","lineage":["https://openalex.org/I113306721"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"M. Okada","raw_affiliation_strings":["Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan","institution_ids":["https://openalex.org/I113306721"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023719583","display_name":"Takashi Kijima","orcid":"https://orcid.org/0000-0003-4249-4021","observed_orcids":["https://orcid.org/0000-0003-4249-4021"]},"institutions":[{"id":"https://openalex.org/I137459256","display_name":"Hyogo Medical University","ror":"https://ror.org/001yc7927","country_code":"JP","type":"education","lineage":["https://openalex.org/I137459256"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"T. Kijima","raw_affiliation_strings":["Division of Respiratory Medicine, Hyogo College of Medicine, Nishinomiya, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Respiratory Medicine, Hyogo College of Medicine, Nishinomiya, Japan","institution_ids":["https://openalex.org/I137459256"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113076850","display_name":"Kohei Aoe","orcid":"https://orcid.org/0000-0001-5019-6249","observed_orcids":["https://orcid.org/0000-0001-5019-6249"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Aoe","raw_affiliation_strings":["Medical Oncology, Yamaguchi-Ube Medical Center, Ube, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Yamaguchi-Ube Medical Center, Ube, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091073688","display_name":"Terufumi Kato","orcid":"https://orcid.org/0000-0002-5853-1424","observed_orcids":["https://orcid.org/0000-0002-5853-1424"]},"institutions":[{"id":"https://openalex.org/I4387152949","display_name":"Kanagawa Cancer Center","ror":"https://ror.org/00aapa202","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4387152949"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"T. Kato","raw_affiliation_strings":["Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan","institution_ids":["https://openalex.org/I4387152949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062505856","display_name":"Nobukazu Fujimoto","orcid":"https://orcid.org/0000-0002-4516-0433","observed_orcids":["https://orcid.org/0000-0002-4516-0433"]},"institutions":[{"id":"https://openalex.org/I4210145491","display_name":"Okayama Rosai Hospital","ror":"https://ror.org/04cmadr83","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210145491"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"N. Fujimoto","raw_affiliation_strings":["Medical Oncology, Okayama Rosai Hospital, Okayama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Okayama Rosai Hospital, Okayama, Japan","institution_ids":["https://openalex.org/I4210145491"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100648645","display_name":"Kazuhiko Nakagawa","orcid":"https://orcid.org/0000-0003-1284-9776","observed_orcids":["https://orcid.org/0000-0003-1284-9776"]},"institutions":[{"id":"https://openalex.org/I916559398","display_name":"Kindai University","ror":"https://ror.org/05kt9ap64","country_code":"JP","type":"education","lineage":["https://openalex.org/I916559398"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"K. Nakagawa","raw_affiliation_strings":["Department of Medical Oncology, Kindai University Faculty of Medicine, Osakasayama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Kindai University Faculty of Medicine, Osakasayama, Japan","institution_ids":["https://openalex.org/I916559398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082711602","display_name":"Yuichiro Takeda","orcid":"https://orcid.org/0000-0002-1412-646X","observed_orcids":["https://orcid.org/0000-0002-1412-646X"]},"institutions":[{"id":"https://openalex.org/I4210094012","display_name":"National Center for Global Health and Medicine","ror":"https://ror.org/00r9w3j27","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210094012"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Y. Takeda","raw_affiliation_strings":["Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan","institution_ids":["https://openalex.org/I4210094012"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086229141","display_name":"Toyoaki Hida","orcid":"https://orcid.org/0000-0003-3537-0020","observed_orcids":["https://orcid.org/0000-0003-3537-0020"]},"institutions":[{"id":"https://openalex.org/I4210133851","display_name":"Aichi Cancer Center","ror":"https://ror.org/03kfmm080","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210133851"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"T. Hida","raw_affiliation_strings":["Thoracic Oncology, Aichi Cancer Center, Nagoya, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic Oncology, Aichi Cancer Center, Nagoya, Japan","institution_ids":["https://openalex.org/I4210133851"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034282329","display_name":"Kuninobu Kanai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I190805021","display_name":"Wakayama Medical University","ror":"https://ror.org/005qv5373","country_code":"JP","type":"education","lineage":["https://openalex.org/I190805021"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"K. Kanai","raw_affiliation_strings":["Pulmonary Medicine and Oncology, Wakayama Medical University, Wakayama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pulmonary Medicine and Oncology, Wakayama Medical University, Wakayama, Japan","institution_ids":["https://openalex.org/I190805021"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108724531","display_name":"Junji Hirano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112155","display_name":"Ono Pharmaceutical (Japan)","ror":"https://ror.org/022jefx64","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210112155"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"J. Hirano","raw_affiliation_strings":["Oncology Clinical Development Planning I, Oncology Clinical Development Unit, Ono Pharmaceutical Co. Ltd., Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Clinical Development Planning I, Oncology Clinical Development Unit, Ono Pharmaceutical Co. Ltd., Osaka, Japan","institution_ids":["https://openalex.org/I4210112155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109099648","display_name":"Yoshinobu Namba","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112155","display_name":"Ono Pharmaceutical (Japan)","ror":"https://ror.org/022jefx64","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210112155"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Y. Namba","raw_affiliation_strings":["Clinical Development Department, Ono Pharmaceutical Co., Ltd. - Headquarters, Osaka, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development Department, Ono Pharmaceutical Co., Ltd. - Headquarters, Osaka, Osaka, Japan","institution_ids":["https://openalex.org/I4210112155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090846902","display_name":"Yuichiro Ohe","orcid":"https://orcid.org/0000-0002-6137-073X","observed_orcids":["https://orcid.org/0000-0002-6137-073X"]},"institutions":[{"id":"https://openalex.org/I4405285273","display_name":"National Cancer Center Hospital","ror":"https://ror.org/053hhpd64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Y. Ohe","raw_affiliation_strings":["Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405285273"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":10,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2528,"currency":"USD","value_usd":2528},"apc_paid":null,"fwci":0.3477,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.60773685,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"31","issue":null,"first_page":"S1076","last_page":"S1076"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11026","display_name":"Occupational and environmental lung diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11026","display_name":"Occupational and environmental lung diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12064","display_name":"Intraperitoneal and Appendiceal Malignancies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/malignant-pleural-mesothelioma","display_name":"malignant pleural mesothelioma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":1.0},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7170000076293945},{"id":"https://openalex.org/keywords/long-term-follow-up","display_name":"long-term follow-up","score":0.8289999961853027},{"id":"https://openalex.org/keywords/japanese-patients","display_name":"Japanese patients","score":0.7099999785423279}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9551607966423035},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6585092544555664},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.5787490606307983},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.5648407340049744},{"id":"https://openalex.org/C2777240266","wikidata":"https://www.wikidata.org/wiki/Q415220","display_name":"Pemetrexed","level":4,"score":0.5314670205116272},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4937838017940521},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.4874880313873291},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.47910597920417786},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4496977925300598},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.44895824790000916},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.4405216872692108},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.4364228844642639},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4192694425582886},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3610544800758362},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3421953320503235},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.23863595724105835},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.21564805507659912},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.07285499572753906},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.annonc.2020.08.1438","doi":"https://doi.org/10.1016/j.annonc.2020.08.1438","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2020.08.1438","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.annonc.2020.08.1438","doi":"https://doi.org/10.1016/j.annonc.2020.08.1438","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2020.08.1438","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2898414995","https://openalex.org/W3116872885","https://openalex.org/W2896984078","https://openalex.org/W2957429634","https://openalex.org/W2948619068","https://openalex.org/W2767870604","https://openalex.org/W2981893587","https://openalex.org/W4200377583","https://openalex.org/W3030969742","https://openalex.org/W7207942570"],"abstract_inverted_index":null,"counts_by_year":[{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2020-10-01T00:00:00"}